Skip to main content

COVID-19

Validation of Core Claims: Dr. Patrick Soon-Shiong on COVID-19 and p53

The provided summary is based on a recent conversation (likely a video interview) with Dr. Patrick Soon-Shiong, a renowned oncologist, biotech entrepreneur, and founder of ImmunityBio. Soon-Shiong has presented similar theses in several public appearances, including interviews with Tucker Carlson in March 2025 and posts on X. The claims are largely plausible and supported by scientific literature where verifiable. However, they represent a mix of established facts, preliminary observations, and speculative hypotheses. The specific study on COVID-19 and p53 inhibition, conducted with Dr. Carlos Cadona, has not been published by November 2025. Soon-Shiong describes it as “soon to be published,” indicating ongoing research but not yet providing peer-reviewed evidence.

Altered Amyloid Plasma Profile in Patients with Debilitating Headaches After SARS-CoV-2 Infection and Vaccination

The Underestimated Side Effect # Headaches are a very common side effect of modRNA injections. In the case of BNT162B2, headaches are particularly prominent in PSUR 3. They initially appear to be a negligible side effect, since everyone experiences headaches occasionally and there are many causes for them. However, in some patients, these headaches persist permanently for months. A case that has resulted in legal action shows that the cause may not be as harmless as it seems.